| Literature DB >> 20478260 |
Lyndee L Scurr1, Gulietta M Pupo, Therese M Becker, Ken Lai, David Schrama, Sebastian Haferkamp, Mal Irvine, Richard A Scolyer, Graham J Mann, Jürgen C Becker, Richard F Kefford, Helen Rizos.
Abstract
Induction of senescence permanently restricts cellular proliferation after oncogenic stimulation thereby acting as a potent barrier to tumor development. The relevant effector proteins may therefore be fundamental to cancer development. A recent study identified IGFBP7 as a secreted factor mediating melanocyte senescence induced by oncogenic B-RAF, which is found commonly in cutaneous nevi. In contrast to the previous report, we demonstrate that B-RAF signaling does not induce IGFBP7 expression, nor the expression of the IGFBP7 targets, BNIP3L, SMARCB1, or PEA15, in human melanocytes or fibroblasts. We also found no correlation between B-RAF mutational status and IGFBP7 protein expression levels in 22 melanoma cell lines, 90 melanomas, and 46 benign nevi. Furthermore, using a lentiviral silencing strategy we show that B-RAF induces senescence in melanocytes and fibroblasts, irrespective of the presence of IGFBP7. Therefore, we conclude that the secreted protein IGFBP7 is dispensable for B-RAF(V600E)-induced senescence in human melanocytes. Copyright (c) 2010 Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20478260 DOI: 10.1016/j.cell.2010.04.021
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582